Neuronano’s technology for Deep Brain Stimulation (DBS) is a novel invention in several important aspects compared to today’s treatments. The technology will facilitate improved safety for patients at every step, while providing a more specific and effective treatment. This will result in fewer side effects and a better life for patients overall.
Why
How
Innovative technology
Neuronano’s innovative technology enables the stimulation of nerve cells in the brain with a brand new kind of electrode that is both thinner and more flexible than those used today. These electrodes can smoothly adapt to the brain’s movements without irritating or damaging tissue, which enables stable contact with the nerve cells located right next to the electrodes. The short distance to living nerve cells permits a lower electrical current for their activation and thus has the potential to produce fewer side effects, if any. Thus a more specific treatment is assured, which will translate into improved efficacy, fewer side effects and improved quality of life for Parkinson’s patients.
Because patient safety is Neuronano’s primary focus, every detail of our technology is carefully considered. We eliminate risks by only using tissue-friendly materials which meet all applicable regulatory requirements and innovative constructions which permit a gentle neurosurgical implantation technique.